Pharmacy Podcast Network

A Story about a Patient | Beyond the Sig

If you didn’t document it, it didn’t happen.  In this episode of Beyond the Sig, Stephanie McGrath, PharmD, Executive Director of the Pennsylvania Pharmacists Care Network sits down with Josh Howland of PioneerRx and Kristen Hartzell of Hartzell’s Pharmacy to discuss how technology is supporting pharmacists in documenting their impact on patient care in an unprecedented way. 
Documentation through the Pharmacist’s eCare Plan is a key component of the Flip the Pharmacy initiative, and a driver in community pharmacy practice innovation.  But at the end of the day, it’s just a story about a patient.  
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Hearts Don’t Break Around Here | GameChangers

Every December, the American Diabetes Association updates the Standards of Medical Care in Diabetes. The guidelines cover sixteen sections from diabetes advocacy to technology updates. Start 2021 off right - learn what changed and what matters most for individuals with diabetes.
This episode is accredited for CPE. Subscribe at CEimpact (https://www.ceimpact.com/pharmacist) and claim your CE today!
Reference: American Diabetes Association. Standards of Medical Care in Diabetes - 2021. Diabetes Cares. January 01, 2021; volume 44, issue supplement 1. https://care.diabetesjournals.org/content/44/Supplement_1 
Disclosure: Dr. Jake Galdo is a speaker for Novo Nordisk in 2021.
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

The Next Phase of Pharmacogenomics & the Pharmacist | PGX for Pharmacists

Becky Winslow, PharmD & Pharmacy Student Kaitlyn Marshall re-launch the PGX for Pharmacists. 
23andMe announced in August of 2020 that it has received a 510(k) clearance from the FDA that allows its direct-to-consumer personal pharmacogenetics report to guide use of two treatments without the need for confirmatory testing.
This action updates a De Novo approval granted to the consumer genomics company in late 2018. That decision allowed 23andMe to market a test for one of 33 variants across multiple genes that could impact metabolization of certain medication, but came with a handful of "special controls." Among these were labeling requirements that warned consumers not to use the product for any medication decisions without additional independent testing.
Guests: 
Becky Winslow, BS, PharmD - Medical Affairs 
Dr. Becky Winslow, earned both her Bachelors of Science in Biology and her doctorate in clinical pharmacy from Campbell University. She earned her Test2Learn(TM) Community-Based Pharmacogenomics Certificate, as well as, her  "Train the Trainer"  certification through NACDS and The University of Pittsburgh School of Pharmacy. 
Dr. Winslow brings over 20 years experience building clinical pharmacy programs, as well as, directing pharmacy business operations in the community setting to inGENEiosu RX. She has patient facing clinical experience as a pharmacist in retail, hospital, public health, and long term care pharmacies. Dr. Winslow founded and has owned her general pharmacy consulting business for over 20 years. In the last 6 years, she has specialized in pharmacogenomics consulting. 
Dr. Winslow's professional associations include being a member of the Clinical Pharmacogenetics Implementation Consortium and The Get the Medications Right Institute.
Now recognized as a community pharmacogenomics subject matter expert, Dr. Winslow is sought after to create and present original pharmacogenomics content and to consult for pharmacogenomics industry vendors and the clients they serve.
Kaitlyn Marshall - PharmD Candidate 2021
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Student Perspective: Engaging Students in Community Pharmacy Practice Transformation | Beyond the Sig

On this episode of Beyond the Sig, Brooke Kulusich, third-year student pharmacist at the University of Pittsburgh School of Pharmacy, talks with Cameron Carpenter, fourth-year student pharmacist at Wilkes Nesbitt School of Pharmacy. In this student-to-student conversation, they discuss ways to engage student pharmacists in practice transformation efforts and Cameron shares his experience from completing an elective community APPE rotation at leading PPCN pharmacies across the state.
Beyond the Sig
https://www.papharmacists.com/page/podcast 
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Connecting the dots for better Health & the MOBE Pharmacist

Look at the big picture with a MOBE Pharmacist.
From your past health history to any new or recent treatments, a MOBE Pharmacist is here to help you put it all together.
They help you build the best medication plan for your health goals by looking at all your prescriptions—across providers, pharmacies, and clinics—and listening to your concerns, as well as what has or hasn’t worked in the past.
You’ll also learn more about how any over-the-counter drugs, dietary supplements, and/or herbal remedies fit into your treatment plan. Your pharmacist will partner with your MOBE Guide to optimize any lifestyle changes you might make to best support your medication situation.
When access isn’t enough: Solving a paradox to serve healthcare’s hidden population. By: Chris Cronin, Chief Executive Officer
https://www.mobeforlife.com/resources/when-access-isnt-enough-solving-a-paradox-to-serve-healthcares-hidden-population
Promoting patient engagement to prevent readmissions By: Leslie Helou, Vice President of Guided Medication Programming
https://www.mobeforlife.com/resources/promoting-patient-engagement-to-prevent-readmissions
Our guests:
Leslie Helou, PharmD, BCPS
Vice President of Medication Strategies
Leslie designs medication initiatives for MOBE participants that are hyper-personalized. These action plans address the complexity of each medication while highlighting the important role they can play when achieving health goals. She inspires her team to help others think critically about, understand, and get the best results possible from their medications while also making other healthy choices. Prior to joining MOBE, Leslie built a career at Upsher-Smith Laboratories, leading efforts to incorporate patient, provider, researcher, and advocacy group insights early in the pharmaceutical research and development process.
Leslie received a doctorate in pharmacy from the University of Minnesota College of Pharmacy before completing a multi-year post-graduate residency in pharmaceutical care and leadership and becoming board certified in pharmacotherapy. She is passionate about mentoring and keeps a relationship with the University to provide unique, business-focused experiences to pharmacy students and graduates.
 Chris Cronin
Chief Executive Officer
Chris leads corporate direction and strategy at MOBE and is motivated daily by guiding the team to do good together. He previously served as the company’s Chief Operating Officer.
Prior to joining MOBE, Chris held various leadership positions at Medtronic in the Cardiac and Restorative Therapies Group, including European Business Director and leading the commercialization of the world’s first MR-Conditional Pacemaker.
Chris has a BS in Accounting from St. John’s University and an MBA from The University of Notre Dame. He lives an active, healthy lifestyle and has completed 15 marathons and three Ironman triathlons, but still loves a big bowl of ice cream.
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Track and Trace: Pharmacists New Responsibilities to Combat Counterfeit Drugs | Locked on Pharmacy

In 2013, Congress passed the Drug Supply Chain Security Act, often called the “track and trace” law, which is designed protect consumers against counterfeit drugs. In November 2020, new requirements for pharmacists took effect.
To learn more about what pharmacists need to know, we spoke with Ilisa Bernstein, senior vice president for government affairs and pharmacy practice at APhA; and Leigh Verbois, director of the Office of Drug Security, Integrity and Response for the FDA’s Center for Drug Evaluation and Research. 
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Designer Drugs | Let’s Pharmonize

We're not talking about drugs made by Louis Vuitton or Dior, no. We're talking about drugs designed to circumvent existing laws by pushing the boundaries of chemistry. Brought to you by the hilarious Ivan Stewart, this episode will entertain as we explore the world of designer drugs.
This is NOT your physician's podcast. Hosts Shane Garrettson and Cal Vandergrift dive into the pharmacy world with fun, interesting, and downright weird topics!
Tune in for NEW episodes, available on Spotify, Apple, Anchor, and more! Check out our Facebook, Twitter, and Instagram pages at Let's Pharmonize to view videos and images relevant to every episode! If you have any questions, comments, or even corrections, e-mail us at pharmonization@gmail.com.
PLEASE READ: Shane and Cal are NOT medical professionals. DO NOT USE the information presented in this podcast to aid in your own personal health or medicinal benefit. This is a light-hearted podcast that should not be taken with the same seriousness as your own personal health,
A special thanks to Kelly Kerr for creating the music used in the intro and outro.
All Rights Reserved
Sponsored by: UltiGuard Safe Pack is the only pen needle product that comes with an all-in-one sharps container. Learn more about why UltiGuard Safe Pack is the best choice for your patients and your pharmacy. Learn more UltiGuard Safe Pack https://www.ulticare.com/ultiguard-safe-pack/podcast 
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

You Say Yes, I Say Nocebo | GameChangers

Myopathy is a common reason for discontinuation of statin medications. The recent SAMSON study examined the nocebo effect and how this may bias patients towards treatment failure. How can clinicians overcome the nocebo effect?
This episode is accredited for CPE. Subscribe at CEimpact (https://www.ceimpact.com/pharmacist) and claim your CE today!
Reference: Wood F, Howard J, Finegold J, et al. N-of-1 Trial of a Statin, Placebo, or No Treatment to Assess Side Effects. N Engl J Med 2020; 383:2182-2184. DOI: 10.1056/NEJMc2031173
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Right in Two | GameChangers

The efficacy of antiretroviral therapy has led to persons with HIV living a near-normal lifespan. But medications only work when used appropriately. The International Antiviral Society-USA Panel published updated recommendations for the treatment and prevention of HIV infections. Treatment of HIV may be distilled into a simple idea - two "nucs" and something else. Learn how to optimize care for your patients.
This episode is accredited for CPE. Subscribe at CEimpact (https://www.ceimpact.com/pharmacist) and claim your CE today!
Reference: Saag MS, Gandhi RT, Hoy JF, et al. Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2020 recommendations of the International Antiviral Society-USA Panel. JAMA. 2020;324(16):1651-1669. Available at: https://www.iasusa.org/2020/11/12/antiretroviral-drugs-treatment-prevention-hiv-infection-adults-2020-recommendations-of-the-international-antiviral-society-usa-panel/ 
The CE for this episode is supported by an educational grant from Xellia Pharmaceuticals, a specialty pharmaceutical company focused on providing important anti-infective treatments against serious and often life-threatening infections. 
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Pharmacy CrossRoads | Pharmacy Owner Donald, “Sparky” Hedden, R.Ph

Donald, “Sparky” Hedden, R.Ph., and the team at McCoy Tygart Drug in Sheridan, Arkansas, won the 2020 Good Neighbor Pharmacy of the Year Award.  Sparky shares examples of things he does that helped his pharmacy earn this award.
McCoy Tygart comes in at about 10,000 feet, 2500 of it dedicated to pharmacy.  In this episode Sparky tells how his pharmacy has adopted an aggressive Medsync program that now boasts 1200 patients and how installing a big tent and hiring high school and college students to be runners allowed him to safely serve patients in this high volume pharmacy.   
Sparky is joined by Robert Mosby, his GNP Business Coach who adds some details on things this remarkable pharmacy does. 
This episode of Pharmacy CrossRoads is sponsored by Compliant Pharmacy Alliance(CPA), learn more here: https://members.compliantrx.com/ 
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

SPOTLIGHT: Drugs of Metal Gear | Let’s Pharmonize

Metal Gear is a series not known for realism, however the detail in the medicine and drugs portrayed in the game turn out surprisingly deep. Mickey Ferguson joins us again to deliver this funny and fascinating analysis of the drugs of Metal Gear. 
This is NOT your physician's podcast. Hosts Shane Garrettson and Cal Vandergrift dive into the pharmacy world with fun, interesting, and downright weird topics!
Tune in for NEW episodes, available on Spotify, Apple, Anchor, and more! Check out our Facebook, Twitter, and Instagram pages at Let's Pharmonize to view videos and images relevant to every episode! If you have any questions, comments, or even corrections, e-mail us at pharmonization@gmail.com.
PLEASE READ: Shane and Cal are NOT medical professionals. DO NOT USE the information presented in this podcast to aid in your own personal health or medicinal benefit. This is a light-hearted podcast that should not be taken with the same seriousness as your own personal health,
A special thanks to Kelly Kerr for creating the music used in the intro and outro.
All Rights Reserved
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Intro to Pharmacy Brokerage | Pharmacy Compliance Guide

Whether you’ve worked your whole career building your business, inherited or purchased from family, or more recently acquired the business, at some point all owners start to think about the next chapters of their life and selling their business.  The world of pharmacy isn’t much different from other businesses in this sense, and it can be hard for an entrepreneur, visionary, and owner to start forecasting life without the business they’ve given so much of their time, energy, focus, and money.
To say there is an emotional attachment may be an understatement.  While some owners can’t wait to dump their business, I’d be willing to bet the majority of pharmacy owners truly love their business, employees, and patients.  Being so engrained in the community, it’s hard for owners not to worry about their patients.  Owners worry about the level of care, or access to care, their patients may, or may not, have should they sell their location.  In some instances that worry for their staff and their community leaves owners holding onto the business much longer than maybe they initially wanted.
Lear more: 
https://www.rjhedges.com/blog/3-roads-to-sell-your-pharmacy 
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

The Launch of the CRx Podcast | January 2021

The Great Valley Publishing Company has partnered with the Pharmacy Podcast Network to deliver the best audio source of education, innovation, and evidence-based podcasts about medical cannabis. The CRx Podcast is the new podcast for the CRX Magazine: http://www.CRxMag.com 
Great Valley Publishing Company has been serving health professionals for over 25 years. Our current B-to-B publications target specific audiences within several areas of health care — health information management, radiology, nutrition, social work, and aging. 
For The Record, Radiology Today, Today's Dietitian, Social Work Today, and Today's Geriatric Medicine are each leaders in their respective fields.
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

The Moderna COVID-19 Vaccine - What Pharmacists Need to Know | Locked On Pharmacy

On December 18, 2020, the Food and Drug Administration authorized the emergency use of the Moderna vaccine, exactly one week after granting the same to the vaccine developed by Pfizer and BioNTech. Two days later, the Advisory Committee on Immunization Practices (ACIP) has issued its recommendations for the next two phases of vaccine allocation.
Our guests are Michael D. Hogue, president of APhA, and a member of a working group of health care leaders that has been advising CDC on the rollout of the vaccine; and Stephan Foster. a member of ACIP, who has also served as a faculty member at the University of Tennessee’s School of Pharmacy and as a captain with the US Public Health Service.
Resources referenced in this podcast:
FDA: Provider Guidance for the Moderna Vaccine (pdf)
FDA: Patient information about the Moderna Vaccine (pdf)
ACIP: Recommendations for Allocation Phase 1b and 1c (pdf)
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Looking Back on 2020 | PUTTcast Episode 12

The PUTTcast Episode 12: Looking Back on 2020
Join hosts PUTT Executive Director Monique Whitney, and Board President Scott Newman; with PUTT board members Lauren Young, Jeremy Counts, & Van Coble as they take a look back over the events of 2020 and discuss what this could mean for pharmacies in the upcoming year. 
Join the Fight: 
https://www.truthrx.org/rxrevolution.html 
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Keep Your Poop to Yourself | GameChangers

Clostridioides difficile is an important cause of morbidity and mortality in the United States with over 500,000 infections annually. The Infectious Disease Society of America released a clinical quality measure focused on treatment of c diff in March 2020. A review of the diagnosis and treatment will help providers improve quality.
This episode is accredited for CPE. Subscribe at CEimpact (https://www.ceimpact.com/pharmacist) and claim your CE today!
The CE for this episode is supported by an educational grant from Xellia Pharmaceuticals, a specialty pharmaceutical company focused on providing important anti-infective treatments against serious and often life-threatening infections. 
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

PCSK9 Inhibitors | Pharmacy Connect Podcast

Pharmacy Connect Podcast: PCSK9 Inhibitors Title: PCSK9 Inhibitors:Understanding the Pharmacist’s Role in Patient Education and Improving Outcomes With Hyperlipidemia Management Special guest: Joseph Saseen, PharmD Professor and Vice Chair, Clinical and Academic Programs; Department of Clinical Pharmacy      Skaggs School of Pharmacy and Pharmaceutical Sciences     University of Colorado Anschutz Medical Campus Objectives Understand the role of PCSK9 inhibitors in the American Heart Association and the American College of Cardiology hyperlipidemia management guidelines Review the pertinent drug information and clinical benefits of the use of PCSK9 inhibitors in the treatment of hyperlipidemia. Describe the role of the pharmacist in patient education and counseling on PCSK9 inhibitors for the treatment of hyperlipidemia through motivational interviewing. CE LINK HERE: https://www.pharmacytimes.org/on-demand/pcsk9-inhibitors-understanding-the-pharmacists-role-in-patient-education-and-improving-outcomes-with-hyperlipidemia-management PTCE - Pharmacy Times Continuing Education See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

The Supreme Court Rules in Favor of Pharmacy | Locked On Pharmacy

On Dec. 10, 2020, the U.S. Supreme Court ruled 8-0 that an Arkansas law regulating how PBMs and pharmacies interact could be enforced, and was not preempted by federal law.
With more than three dozen other states debating or passing such legislation, the ruling could have nationwide impact. The CEOs of national pharmacy organization were unanimous in hailing the decision.
In this episode, three guests discuss the case: Rep. Buddy Carter (R-Georgia); John Vinson, CEO of the Arkansas Pharmacists Association; and Scott Knoer, Executive Vice President and CEO of the American Pharmacists Association.
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Enhancing Diabetes Management: Important Technological and Therapeutic Achievements

For over a century, the treatments and technologies used to treat diabetes have evolved. New tools are now available to aid in diabetes management and to help patients further manage and better control their glucose levels.
1,2 Through their recently announced collaboration, Dexcom and Lilly are at the forefront of enhancing diabetes care.
3 In this episode Dr. Chad Worz and guest speakers Deirdre Ibsen and Dr. Thomas Blevins discuss these important technological and therapeutic achievements over time, as well as 2 products available from Dexcom and Lilly and how they may benefit patients with diabetes.
References: 
Dexcom G6 Pro User Guide. https://dexcompdf.s3-us-west-2.amazonaws.com/Dexcom-G6-Pro-User-Guide.pdf. Accessed October 12, 2020.
Lyumjev [Prescribing Information]. Indianapolis, IN: Lilly USA, LLC.
Eli Lilly and Company. Lilly and Dexcom team up on new program to help improve diabetes management. https://provider.dexcom.com/products/dexcom-g6-pro/training-resources. Accessed October 12, 2020.
Centers for Disease Control. National Diabetes Statistics Report 2020 Estimates of Diabetes and Its Burden in the United States. https://www.cdc.gov/diabetes/pdfs/data/statistics/national-diabetes-statistics-report.pdf. Accessed October 1, 2020.
American Diabetes Association. Diabetes and Quality of Life. http://journal.diabetes.org/diabetesspectrum/00v13n1/pg48.htm. Accessed October 1, 2020.
American Diabetes Association. Caring for the Caregiver. https://spectrum.diabetesjournals.org/content/17/1/37.full-text.pdf. Accessed October 15, 2020.
Ali MK, Bullard KM, Gregg EW. Achievement of goals in U.S. diabetes care, 1999-2010. N Engl J Med. 2013;369(3):287-288.
Foster NC, Beck RW, Miller KM, et al. State of type 1 diabetes management and outcomes from the T1D Exchange in 2016-2018. Diabetes Technol Ther. 2019;21(2):66-72.
American Diabetes Association. 7. Diabetes Technology: Standards of Medical Care in Diabetes-2020. Diabetes Care. 2020;43(suppl 1):S77-S88.
Hirsch IB. History of Glucose Monitoring. https://professional.diabetes.org/sites/professional.diabetes.org/files/media/db201811.pdf. Accessed October 1, 2020.
White JR. A brief history of the development of diabetes medications. Diabetes Spectr. 2014;27(2):82-86.
Science History Institute. Frederick Banting, Charles Best, James Collip, and John Macleod. https://www.sciencehistory.org/historical-profile/frederick-banting-charles-best-james-collip-and-john-macleod. Accessed October 1, 2020.
American Diabetes Association. Timeline. https://www.diabetes.org/resources/timeline. Accessed October 9, 2020.
Humalog [Prescribing Information]. Indianapolis, IN: Lilly USA, LLC.
Selam J-L. Evolution of diabetes insulin delivery devices. J Diabetes Sci Technol. 2010;4(3):505-513.
American Association of Diabetes Educators. Insulin Injection Know-How. https://www.diabeteseducator.org/docs/default-source/legacy-docs/_resources/pdf/general/Insulin_Injection_How_To_AADE.pdf. Accessed October 1, 2020.
Hyllested-Winge J, Jensen KH, Rex J. A review of 25 years’ experience with the NovoPen® family of insulin pens in the management of diabetes mellitus. Clin Drug Investig. 2010;30(10):643-674.
Eli Lilly and Company. Lilly Launches KwikPen(TM) for Humalog(R) and Humalog Mixtures [press release]. https://investor.lilly.com/news-releases/news-release-details/lilly-launches-kwikpentm-humalogr-and-humalog-mixtures. Accessed October 12, 2020.
American Diabetes Association. 6. Glycemic Targets: Standards of Medical Care in Diabetes-2020. Diabetes Care. 2020;43(suppl 1):S66-S76.
Garber AJ, Handelsman Y, Grunberger G, et al. Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm - 2020 executive summary. Endocr Pract. 2020;26(1):107-139.
Fonseca VA, Grunberger G, Anhalt H, et al. Continuous glucose monitoring: a consensus conference of the American Association of Clinical Endocrinologists and American College of Endocrinology. Endocr Pract. 2016;22(8):1008-1021.
Battelino T, Danne T, Bergenstal RM, et al. Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range. Diabetes Care. 2019;42(8):1593-1603.
Dexcom G6 Pro Unblinded Patient Guide. https://dexcompdf.s3-us-west-2.amazonaws.com/Dexcom-G6-Pro-Unblinded-Patient-Guide.pdf. Accessed October 12, 2020.
Dexcom Announces FDA Clearance of New Dexcom G6 Pro CGM. https://provider.dexcom.com/industry-news/fda-authorizes-dexcom-g6-pro. Accessed October 2, 2020.
Beck RW, Riddlesworth T, Ruedy K, et al. Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: the DIAMOND randomized clinical trial. 2017;317(4):371-378.
Beck RW, Riddlesworth TD, Ruedy K, et al. Continuous glucose monitoring versus usual care in patients with type 2 diabetes receiving multiple daily insulin injections: a randomized trial. Ann Intern Med. 2017;167(6):365-374.
Polonsky WH, Hessler D, Ruedy KJ, Beck RW. The impact of continuous glucose monitoring on markers of quality of life in adults with type 1 diabetes: further findings from the DIAMOND randomized clinical trial. Diabetes Care. 2017;40(6):736-741.
Pratley RE, Kanapka LG, Rickels MR, et al. Effect of continuous glucose monitoring on hypoglycemia in older adults with type 1 diabetes: a randomized clinical trial. 2020;323(23):2397-2406.
Ruedy KJ, Parkin CG, Riddlesworth TD, Graham C. Continuous glucose monitoring in older adults with type 1 and type 2 diabetes using multiple daily injections of insulin: results from the DIAMOND trial. J Diabetes Sci Technol. 2017;11(6):1138-1146.
Lind M, Polonsky W, Hirsch IB, et al. Continuous glucose monitoring vs conventional therapy for glycemic control in adults with type 1 diabetes treated with multiple daily insulin injections: the GOLD randomized clinical trial. 2017;317(4):379-387.
Frequently Asked Questions. https://provider.dexcom.com/products/dexcom-g6-pro/faqs. Accessed October 15, 2020.
Dexcom Products: Dexcom G6 Pro. https://provider.dexcom.com/products/professional-cgm. Accessed October 15, 2020.
How to Customize Alarm and Alerts. https://www.dexcom.com/faqs/how-to-customize-alarm-and-alerts. Accessed October 15, 2020.
Trend Arrows and Treatment Decisions. https://s3-us-west-2.amazonaws.com/dexcompdf/HCP_Website/LBL015804+G6+Trend+Arrows+and+Treatment+Decisions.pdf. Accessed October 15, 2020.
Why CGM? https://provider.dexcom.com/why-cgm. Accessed October 12, 2020.
Pharmacy Coverage. https://provider.dexcom.com/pharmacy-coverage. Accessed October 12, 2020.
Is There Reimbursement for Using Dexcom G6 Pro? https://provider.dexcom.com/faqs/there-reimbursement-using-dexcom-g6-pro. Accessed October 12, 2020.
Hypoglycemia Unawareness. https://provider.dexcom.com/education-research/clinical-evidence/clinical-studies/real-time-continuous-glucose-monitoring-cgm. Accessed October 15, 2020.
Garg SK, Wernicke-Panten K, Wardecki M, et al. Safety, immunogenicity, and glycemic control of insulin aspart biosimilar SAR341402 versus originator insulin aspart in people with diabetes also using insulin glargine: 12-month results from the GEMELLI 1 trial. Diabetes Technol Ther. 2020;22(7):516-526.
Dexcom G6 Pro Blinded Patient Guide. https://dexcompdf.s3-us-west-2.amazonaws.com/HCP_Website/Dexcom+G6+Pro+Resources/LBL017177+Rev+004+Artwork%2C+Dexcom+G6+Pro+Blinded+Patient+Guide+US_r5_WEB.pdf. Accessed November 24, 2020.
Dexcom CLARITY Diabetes Management Software. https://www.dexcom.com/clarity. Accessed May 15, 2020.
Blevins T, Zhang Q, Frias JP, Jinnouchi H, Chang AM. Randomized double-blind clinical trial comparing ultra rapid lispro with lispro in a basal-bolus regimen in patients with type 2 diabetes: PRONTO-T2D. Diabetes Care. Published online July 2, 2020. doi: 10.2337/dc19-2550.
Klaff L, Cao D, Dellva MA, et al. Ultra rapid lispro improves postprandial glucose control compared with lispro in patients with type 1 diabetes: results from the 26-week PRONTO-T1D study. Diabetes Obes Metab. 2020;22(10):1799-1807.
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices

What are ’Learning Health Systems’ special guest Allen Flynn, PhD, PharmD | FutureDose.tech

Todays FutureDose.tech guest is Allen Flynn, PhD & PharmD,  Assistant Professor, Department of Learning Health Sciences at the University of Michigan. 
It has been reported that 70% of pharmacists’ time is spent on non-cognitive activities such as medication distribution. As such, the industry recognizes that more automation is needed so that pharmacists and pharmacy technicians can spend more time on patient focused activities that improve outcomes. Allen Flynn, PhD & PharmD, is one of the industry trailblazers researching and building tools that will enable pharmacists to spend more time by the bedside.
Listen in as David Berkowitz and Allen Flynn discuss some of the problems that need to be solved from a clinical and technical perspective in order to automate more non-value added pharmacy tasks.
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices